Study ID: TV48125-CNS-80005
Study Title
- Expanded Access Program for Patients With Migraine
Teva Identifier
- TV48125-CNS-80005
ClinicalTrials.gov Identifier
- NCT03539393
Study Status
- No longer available
Trial Condition(s)
- Migraine
Interventions
- Drug: Fremanezumab
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 70 Years
Trial Duration
- 01/00/1900 - 01/00/1900
Study Type
Expanded Access:Treatment IND/Protocol